Literature DB >> 18381569

Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone.

P Bougnères1, M François, L Pantalone, D Rodrigue, C Bouvattier, E Demesteere, D Roger, N Lahlou.   

Abstract

BACKGROUND: The neonatal-midinfancy surge in pulsatile gonadotropin secretion is attributable to an increase in GnRH pulse amplitude and is associated with a rapid expansion of Leydig and Sertoli cell populations with concomitant surges in testosterone, inhibin, and anti-Mullerian hormone production as well as an increase in testicular volume. Boys with congenital hypogonadotropic hypogonadism (HH) do not activate these processes. A potential cause for azoospermia and infertility in adult life is deficient proliferation of immature Sertoli cells before and during puberty due to the absence of FSH.
OBJECTIVE: The objective of the study was to investigate whether early postnatal continuous sc infusion of gonadotropins could mimic the physiological growth of testes and to evaluate responses of the Leydig and Sertoli cells to early gonadotropin replacement. DESIGN AND METHODS: Two neonates (P1 with hypotuitarism and P2 with HH) with micropenis and microorchidism were treated for 6 months with high doses of recombinant LH and FSH (a gift of Luveris and Gonal-F from Serono, Lyon, France) delivered sc with an insulin pump.
RESULTS: Gonadotropin continuous sc infusion increased mean serum LH and FSH to normal or supranormal levels. Mean testosterone increased from undetectable levels to 7.6 and 5.2 nmol/liter, respectively, in P1 and P2. Inhibin B and anti-Müllerian hormone increased to normal levels. Mean testicular volume increased from 0.45 to 0.57 ml at birth to 2.10 ml at 7 months. Stretched penile length increased from 8 to 30 mm (P1) and 12 to 48 mm (P2).
CONCLUSIONS: The present regimen induced physiological postnatal testes growth and high-normal activation of Leydig and Sertoli cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381569     DOI: 10.1210/jc.2008-0121

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  Insufficient androgen and FSH signaling may be responsible for the azoospermia of the infantile primate testes despite exposure to an adult-like hormonal milieu.

Authors:  Subeer S Majumdar; Kanchan Sarda; Indrashis Bhattacharya; Tony M Plant
Journal:  Hum Reprod       Date:  2012-06-04       Impact factor: 6.918

Review 2.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 3.  The inconspicuous penis in children.

Authors:  Marcello Cimador; Pieralba Catalano; Rita Ortolano; Mario Giuffrè
Journal:  Nat Rev Urol       Date:  2015-04-07       Impact factor: 14.432

Review 4.  Minipuberty in Klinefelter syndrome: Current status and future directions.

Authors:  Lise Aksglaede; Shanlee M Davis; Judith L Ross; Anders Juul
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-06-01       Impact factor: 3.908

5.  Treatment of congenital hypogonadotropic hypogonadism in male patients.

Authors:  Hae Sang Lee; Young Suk Shim; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-09-30

6.  Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development.

Authors:  Kahina Boukari; Geri Meduri; Sylvie Brailly-Tabard; Jean Guibourdenche; Maria Luisa Ciampi; Nathalie Massin; Laetitia Martinerie; Jean-Yves Picard; Rodolfo Rey; Marc Lombès; Jacques Young
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

7.  Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism.

Authors:  Andrew A Dwyer; Gerasimos P Sykiotis; Frances J Hayes; Paul A Boepple; Hang Lee; Kevin R Loughlin; Martin Dym; Patrick M Sluss; William F Crowley; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2013-09-13       Impact factor: 5.958

8.  Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life.

Authors:  Julie Sarfati; Claire Bouvattier; Hélène Bry-Gauillard; Alejandra Cartes; Jérôme Bouligand; Jacques Young
Journal:  Orphanet J Rare Dis       Date:  2015-06-09       Impact factor: 4.123

9.  Adverse pathophysiological influence of early testosterone therapy on the testes of boys with higher grade sex chromosome aneuploidies (HGAs): a retrospective, cross-sectional study.

Authors:  M Spaziani; C Tarantino; C Pozza; A Anzuini; F Panimolle; G Papi; D Gianfrilli; A Lenzi; A F Radicioni
Journal:  J Endocrinol Invest       Date:  2020-10-24       Impact factor: 4.256

Review 10.  Micropenis: etiology, diagnosis and treatment approaches.

Authors:  Nihal Hatipoğlu; Selim Kurtoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.